Study Using the SpinalStim Device Following Lumbar Fusion Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

206 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-28

Study Completion Date

2021-07-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines the effect of adjunctive use of the SpinalStim bone growth stimulator on lumbar fusion rate in high risk subjects who have had lumbar fusion surgery. All participants will wear the bone growth stimulator for a minimum of 2 hours/day for 6 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study Using the CervicalStim Device Following Cervical Fusion

NCT03177473

Vertebral Cervical Fusion Syndrome Degenerative Disc Disease

COMPLETED

Titanium Surgical Mesh and MOSS-Miami Screws for Lumbar Fusion.

NCT00215319

Degenerative Disc Disease

COMPLETED PHASE3

Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device

NCT06355791

Degenerative Conditions of the Lumbar Spine Lumbar Spinal Stenosis Spondylolisthesis

RECRUITING NA

A Prospective Analysis of the Efficacy of Allosync Expand and Autograft Bone Graft in Open Lumbar Spinal Fusion

NCT06415110

Spondylolisthesis, Grade 1

ENROLLING_BY_INVITATION

OsteoStrux™ Collagen Ceramic Scaffold in Instrumented Lumbar Spine Fusion

NCT01873586

Degenerative Changes Stenosis Spondylosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this post market prospective study is to examine the effect of the adjunctive use of the Orthofix SpinalStim™ device on lumbar fusion rate in high risk subjects who have undergone lumbar fusion surgery. High risk subjects are those who are currently using nicotine, who are having a multi-level fusion, who have had a prior failed fusion at any lumbar level, who are diabetic or who are osteoporotic. Because this is a post market prospective study, subjects who are enrolled in this study will be identified by the Investigator as needing lumbar fusion surgery and asked if they would like to participate in a study looking at the efficacy of lumbar fusion with adjunctive use of the SpinalStim bone growth simulator. The type of lumbar fusion surgery performed (lateral lumbar interbody fusion \[XLIF\], posterior lumbar interbody fusion \[PLIF\], anterior lumbar interbody fusion \[ALIF\], posterolateral fusion) is up to the Investigator; the subjects in the study must be agreeable to using the bone growth stimulator daily for 6 months post surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Spine Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pulsed Electromagnetic Field

one group all of whom will be treated with the PEMF device

SpinalStim

Intervention Type DEVICE

PEMF osteogenesis stimulator

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SpinalStim

PEMF osteogenesis stimulator

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female, ≥ 18 years of age at the time of Informed Consent
2. Requires a lumbar fusion surgery within 30 days of signing Informed Consent.

a. Surgical approach is according to physician's discretion.
3. Subject has one or more risk factors:

* Is currently using nicotine
* multi-level lumbar fusion surgery planned
* Prior failed fusion at any lumbar level
* Subject reported diabetes
* Subject reported osteoporosis
4. Body mass index ≤ 45 kg/m2 at the time of consent.
5. Must have reliable access to an iPhone or an iPad with Wi-Fi access for downloading the free device-specific app (iPhone 5S or higher, iPad, iPad Pro, iPad mini or iTouch using iOS v9.3 or later). When the android version of the mobile app for the SpinalStim becomes available (estimated to be Dec. 2017), subjects who have reliable access to devices using android operating systems will be eligible for study inclusion.
6. Able and willing to complete electronic questionnaires and able to read and understand study instructions in English
7. Able and willing to comply with the study plan and able to understand and sign the study-specific ICF.

Exclusion Criteria

1. Scoliosis greater than 30 degrees
2. Current alcoholism or drug abuse, and/or any known current addiction to pain medications or medical marijuana
3. Any active malignancy or prior history of malignancy within last 5 years prior to fusion (except basal cell carcinoma of the skin).
4. Any clinically significant finding that places the subject at health risk, impacts the study, or affects completion of the study, in the opinion of the Investigator
5. Any psychiatric illness that prevents subject from completing the assessments accurately, in the opinion of the Investigator
6. Prisoners.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No